JB Chemicals & Pharmaceuticals announced its revenue growth of 10% to Rs 601cr in Q3 FY22

JB Chemicals & Pharmaceuticals Limited (JB), one of the fastest growing pharmaceutical companies in India, announced its financial results for the third quarter ended December 31, 2021.JB Chemicals & Pharmaceuticals Limited (JB), one of the fastest g

First Covid oral antiviral pill sees sales of just Rs 46 crore in January

Molnupiravir, the first oral antiviral for treatment of mild to moderate Covid approved by the US Food and Drug Administration (FDA), seems to have bombed in the domestic market. This is far different than the first two waves when Covid therapies had

Why Pharmaceutical Companies are Collaborating with Health Tech Firms

Recently, pharmaceutical company Abbott said it has tied up with various health tech firms like BeatO, Sugar.fit, PharmaEasy, GOQii, 1MG and Zyla for diabetes care.

Emcure Pharma arm developing Covid vaccine aiming Omicron variant

Gennova Biopharmaceuticals, a subsidiary of Pune-based drugmaker Emcure Pharmaceuticals, is developing a Covid-19 vaccine on its mRNA platform which will target the Omicron variant, the strain that is driving the third coronavirus infection wave in t

Biological E has sought extension of its vaccine shelf life to 12 months

Hyderabad-based Biological E has sought extension of shelf life of its Covid-19 vaccine Corbevax by up to 12 months from India's drug regulatory authority.Hyderabad-based Biological E has sought extension of shelf life of its Covid-19 vaccine Corbeva

Tata Medical says, OmiSure RT-PCR test is enhanced to detect BA.2 sub-lineages of Omicron

Tata Medical and Diagnostics on Tuesday said its OmiSure RT-PCR test has been upgraded to detect the new BA.2 sub-lineages of Omicron. In an evaluation carried out by ICMR and the Virus Research & Diagnostics Laboratory, Kasturba Hospital for Infecti

DCGI gives nod to SII's proposal for manufacture of vaccine against omicron

The Drugs Controller General of India (DCGI) has approved Serum Institute of India's proposal to manufacture a vaccine against omicron variant of coronavirus for examination, test and analysis, official sources said. The Drugs Controller General of I

Challenges in running a pharmaceutical formulation business

Recently, the board of directors of Panacea Biotec Pharma Limited has approved the sale of its domestic business assets, which include its pharmaceutical formulations brands in India and Nepal

Vaccine may soon be available for 12-18 age group: Cadila Healthcare

Cadila Healthcare (Zydus Cadila) said it plans to soon roll out its Covid-19 vaccine ZyCoV-D for the 12-18 age group.Cadila Healthcare (Zydus Cadila) said it plans to soon roll out its Covid-19 vaccine ZyCoV-D for the 12-18 age group.Cadila Healthc

NTAGI to meet on Friday for review of Covovax and Corbevax

Covid-19 working group of the National Technical Advisory Group on immunisation (NTAGI) is expected to meet on Friday to review trials data of Covovax and Corbevax for their use in children, people in the know said. At present children between the ag

© 2025 India Pharma Outlook. All Rights Reserved.